| 1 |
tumor protein p53
(546 times)
|
Neoplasms
(187 times)
|
EGFR (52 times)
KRAS (36 times)
NGS (31 times)
|
1993 Localization of the tumour protein, TP53, on porcine chromosome 12q12-q14.
|
| 2 |
tumor suppressor p53
(41 times)
|
Neoplasms
(17 times)
|
HPV (3 times)
mutp53 (2 times)
PCR (2 times)
|
2002 Activation of nuclear factor kappaB in radioresistance of TP53-inactive human keratinocytes.
|
| 3 |
tumor suppressor protein p53
(28 times)
|
Neoplasms
(9 times)
|
ATM (3 times)
CI (3 times)
OR (2 times)
|
1995 Assignment of three loci: tumor suppressor protein-53 (TP53), retinoic acid receptor A (RARA), collagen 1A1 (COL1A1) to Syrian hamster chromosome 9. Evidence that this chromosome is homologous with human chromosome 17, mouse chromosome 11, and rat chromosome 10.
|
| 4 |
tumor antigen p53
(11 times)
|
Complementary Therapies
(3 times)
|
GO (5 times)
KEGG (5 times)
PPI (4 times)
|
2016 The future therapy of endometrial cancer: microRNA's functionality, capability, and putative clinical application.
|
| 5 |
p53 tumor suppressor gene
(7 times)
|
Cell Biology
(2 times)
|
EMSAs (1 time)
FFPE (1 time)
NSCLCs (1 time)
|
1998 p53 and brain tumors: from gene mutations to gene therapy.
|
| 6 |
TP53-MT
(4 times)
|
Translational Medical Research
(1 time)
|
OS (2 times)
ACPP (1 time)
ALK (1 time)
|
2019 DNA methylation signature is prognostic of choroid plexus tumor aggressiveness.
|
| 7 |
wild-type p53 gene
(4 times)
|
Genetics
(1 time)
|
5-FU (1 time)
CRC (1 time)
PCR (1 time)
|
1998 p53: prospects for cancer gene therapy.
|
| 8 |
TP53mut
(2 times)
|
Neoplasms
(1 time)
|
AML (1 time)
HMA (1 time)
OS (1 time)
|
2000 Raf-1 kinase activity predicts for paclitaxel resistance in TP53mut, but not TP53wt human ovarian cancer cells.
|
| 9 |
TP53wt
(2 times)
|
Neoplasms
(2 times)
|
ALL (1 time)
hyper-CVAD (1 time)
TP53mut (1 time)
|
2000 Raf-1 kinase activity predicts for paclitaxel resistance in TP53mut, but not TP53wt human ovarian cancer cells.
|
| 10 |
p53 tumor antigen gene
(1 time)
|
Genetics
(1 time)
|
---
|
1991 Chromosomal localization of two human zinc finger protein genes, ZNF24 (KOX17) and ZNF29 (KOX26), to 18q12 and 17p13-p12, respectively.
|
| 11 |
Then, antitumor protein53
(1 time)
|
Neoplasms
(1 time)
|
AGR3 (1 time)
HGSC (1 time)
LGSC (1 time)
|
2018 Combination of TP53 and AGR3 to distinguish ovarian high-grade serous carcinoma from low-grade serous carcinoma.
|
| 12 |
three continents for p53 gene
(1 time)
|
Science
(1 time)
|
HBV (1 time)
|
1994 Genetic heterogeneity of hepatocellular carcinoma.
|
| 13 |
through stabilization of p53
(1 time)
|
Genetics
(1 time)
|
---
|
2007 Parthenolide sensitizes cells to X-ray-induced cell killing through inhibition of NF-kappaB and split-dose repair.
|
| 14 |
TP53 and D17S786
(1 time)
|
Neoplasms
(1 time)
|
LOH (1 time)
|
2000 Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53.
|
| 15 |
TP53 codon 72
(1 time)
|
Biology
(1 time)
|
---
|
2007 TP53 codon 72 polymorphism as a risk factor for cardiovascular disease in a Brazilian population.
|
| 16 |
TP53 frameshift mutation
(1 time)
|
Clinical Medicine
(1 time)
|
ctDNA (1 time)
|
2017 Rapid Changes in Circulating Tumor DNA in Serially Sampled Plasma During Treatment of Breast Cancer: A Case Report.
|
| 17 |
TP53.del42bp
(1 time)
|
Biochemistry
(1 time)
|
Ad (1 time)
ECa (1 time)
UPSC (1 time)
|
2006 A novel loss-of-function mutation in TP53 in an endometrial cancer cell line and uterine papillary serous carcinoma model.
|
| 18 |
TP63, a p53
(1 time)
|
Molecular Biology
(1 time)
|
MFG-E8 (1 time)
TA (1 time)
|
2007 p63(TP63) elicits strong trans-activation of the MFG-E8/lactadherin/BA46 gene through interactions between the TA and DeltaN isoforms.
|
| 19 |
transcription factor p53
(1 time)
|
Cell Biology
(1 time)
|
Cip1 (1 time)
|
2007 p18(Hamlet) mediates different p53-dependent responses to DNA-damage inducing agents.
|
| 20 |
transduced with a dominant negative p53
(1 time)
|
Genetics
(1 time)
|
---
|
2007 Human glioblastoma U87MG cells transduced with a dominant negative p53 (TP53) adenovirus construct undergo radiation-induced mitotic catastrophe.
|
| 21 |
transgene for p53
(1 time)
|
Neoplasms
(1 time)
|
OV (1 time)
|
2017 Combining Oncolytic Virotherapy with p53 Tumor Suppressor Gene Therapy.
|
| 22 |
TSGs, P53
(1 time)
|
Endocrinology
(1 time)
|
CCND1 (1 time)
PETs (1 time)
TSGs (1 time)
|
2012 Molecular pathology and genetics of pancreatic endocrine tumours.
|
| 23 |
tumor necrosis protein 53
(1 time)
|
Medical Informatics
(1 time)
|
GO (1 time)
HIF-1 (1 time)
IL-10 (1 time)
|
2022 Molecular Mechanism of Dayuan Decoction in the Treatment of Fever Based on Network Pharmacology.
|
| 24 |
Tumor P53 protein
(1 time)
|
Neoplasms
(1 time)
|
IHC (1 time)
|
2001 Ethnicity delineates different genetic pathways in malignant glioma.
|
| 25 |
tumor protein/suppressor p53
(1 time)
|
Biological Science Disciplines
(1 time)
|
MALDI-TOF MS (1 time)
PPARalpha (1 time)
|
2018 2D DIGE proteomic analysis reveals fasting-induced protein remodeling through organ-specific transcription factor(s) in mice.
|
| 26 |
Tumoral Protein p53
(1 time)
|
Medicine
(1 time)
|
EGFR (1 time)
KRAS (1 time)
|
2016 Multiplex Detection of Rare Mutations by Picoliter Droplet Based Digital PCR: Sensitivity and Specificity Considerations.
|
| 27 |
wild-type p53
(1 time)
|
Science
(1 time)
|
LT (1 time)
MCCs (1 time)
MCV (1 time)
|
2019 Dual inhibition of MDM2 and MDM4 in virus-positive Merkel cell carcinoma enhances the p53 response.
|
| 28 |
wild-type p53 protein
(1 time)
|
Gynecology
(1 time)
|
---
|
2001 Polymorphism of TP53 codon 72 and the risk of cervical cancer among Korean women.
|
| 29 |
wild-type tumour suppressor p53
(1 time)
|
Neoplasms
(1 time)
|
CAPOX (1 time)
KRAS (1 time)
|
2011 Combined KRAS and TP53 mutation status is not predictive in CAPOX-treated metastatic colorectal cancer.
|
A Search Service for Abbreviation / Long Form